{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coronavirus disease 2019", "Molecular dynamics simulations", "Severe Acute Respiratory Syndrome Coronavirus 2", "Structural flexibility"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35856008", "DateRevised": {"Year": "2022", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1016/j.sciaf.2022.e01279"], "Journal": {"ISSN": "2468-2276", "JournalIssue": {"Volume": "17", "PubDate": {"Year": "2022", "Month": "Sep"}}, "Title": "Scientific African", "ISOAbbreviation": "Sci Afr"}, "ArticleTitle": "Molecular modeling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins.", "Pagination": {"StartPage": "e01279", "MedlinePgn": "e01279"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is one of the major health threats the world has experienced. In order to stem the tide of the virus and its associated disease, rapid efforts have been dedicated to identifying credible anti-SARS-CoV-2 drugs. This study forms part of the continuing efforts to develop anti-SARS-CoV-2 molecules and employed a computational structure-activity relationship approach with emphasis on 99 plant secondary metabolites from eight selected African medicinal plants with proven therapeutic benefits against respiratory diseases focusing on the viral protein targets [Spike protein (Sgp), Main protease (Mpro), and RNA-dependent RNA polymerase (RdRp)]. The results of the molecular dynamics simulation of the best docked compounds presented as binding free energy revealed that three compounds each against the Sgp (VBS, COG and ABA), and Mpro (COR, QOR and ABG) had higher and better affinity for the proteins than the respective reference drugs, cefoperazone (CSP) and Nelfinavir (NEF), while four compounds (HDG, VBS, COR and KOR) had higher and favorable binding affinity towards RdRp than the reference standard, ramdesivir (RDS). Analysis of interaction with the receptor binding domain amino acid residues of Sgp showed that VBS had the highest number of interactions (17) relative to 14 and 13 for COG and ABA, respectively. For Mpro, COR showed interactions with catalytic dyad residues (His172 and Cys145). Compared to RDS, COR, HDG, VBS and KOR formed 19, 18, 17 and 12 H-bond and Van der Waal bonds, respectively, with RdRp. Furthermore, structural examination of the three proteins after binding to the lead compounds revealed that the compounds formed stable complexes. These observations suggest that the identified compounds might be beneficial in the fight against COVID-19 and are suggested for further <i>in vitro</i> and <i>in vivo</i> experimental validation."], "CopyrightInformation": "\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology (DUT), PO Box 1334, Durban, 4000, South Africa."}], "LastName": "Uhomoibhi", "ForeName": "J O", "Initials": "JO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology (DUT), PO Box 1334, Durban, 4000, South Africa."}], "LastName": "Idowu", "ForeName": "K A", "Initials": "KA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology (DUT), PO Box 1334, Durban, 4000, South Africa."}], "LastName": "Shode", "ForeName": "F O", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology (DUT), PO Box 1334, Durban, 4000, South Africa."}], "LastName": "Sabiu", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Sci Afr", "NlmUniqueID": "101771789", "ISSNLinking": "2468-2276"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., L, Peiris M., Wu J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177\u20131179.", "ArticleIdList": ["PMC7121626", "32074444"]}, {"Citation": "Lee G.M. The importance of context in Covid-19 vaccine safety. N. Engl. J. Med. 2021;385:1138\u20131140.", "ArticleIdList": ["PMC8427533", "34432973"]}, {"Citation": "Jamiu A.T., Aruwa C.E., Abdulakeem I.A., Ajao A.A., Sabiu S. Phytotherapeutic evidence against coronaviruses and prospects for COVID-19. Pharmacogn. J. 2020;12"}, {"Citation": "Konstantinidou S.K., Papanastasiou I.P. Repurposing current therapeutic regimens against SARS-CoV-2. Exp. Ther. Med. 2020;20:1845\u20131855.", "ArticleIdList": ["PMC7401312", "32782493"]}, {"Citation": "Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2020;71:732\u2013739.", "ArticleIdList": ["PMC7108130", "32150618"]}, {"Citation": "Shode F.O., Idowu A.S.K., Uhomoibhi O.J., Sabiu S. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. J. Biomol. Struct. Dyn. 2021:1\u201316.", "ArticleIdList": ["PMC7898306", "33590806"]}, {"Citation": "Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586\u2013590.", "ArticleIdList": ["PMC7079879", "32125455"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.", "ArticleIdList": ["PMC7102627", "32142651"]}, {"Citation": "Khan R.J., Jha R.K., Amera G.M., Jain M., Singh E., Pathak A., Singh R.P., Muthukumaran J., Singh A.K. Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. J. Biomol. Struct. Dyn. 2021;39:2679\u20132692.", "ArticleIdList": ["PMC7189412", "32266873"]}, {"Citation": "Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q., Ming Z., Zhang L. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368(80):779\u2013782.", "ArticleIdList": ["PMC7164392", "32277040"]}, {"Citation": "Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10:766\u2013788.", "ArticleIdList": ["PMC7102550", "32292689"]}, {"Citation": "Depfenhart M., Lemperle G., Meyer M., Rautenbach M., Bertossi D., de Villiers D.A. A SARS-CoV-2 prophylactic and treatment: a counter argument against the sole use of chloroquine. Am J Biomed Sci Res. 2020;8:248\u2013251."}, {"Citation": "Olaleye O.A., Kaur M., Onyenaka C., Adebusuyi T. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2-Spike protein interaction in vitro. Heliyon. 2021;7:e06426.", "ArticleIdList": ["PMC7951571", "33732940"]}, {"Citation": "Teimury A., Khaledi E.M. Current options in the treatment of COVID-19: a review. Risk Manag. Healthc. Policy. 2020;13:1999.", "ArticleIdList": ["PMC7549493", "33116980"]}, {"Citation": "A. Basu, A. Sarkar, U. Maulik, Computational approach for the design of potential spike protein binding natural compounds in SARS-CoV2, (2020)."}, {"Citation": "Hall Jr D.C., Ji H.-F. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Med. Infect. Dis. 2020;35", "ArticleIdList": ["PMC7152904", "32294562"]}, {"Citation": "K. Senathilake, S. Samarakoon, K. Tennekoon, Virtual screening of inhibitors against spike glycoprotein of 2019 novel corona virus: A drug repurposing approach, (2020)."}, {"Citation": "Maurya V.K., Kumar S., Bhatt M.L.B., Saxena S.K. Therapeutic development and drugs for the treatment of COVID-19. Coronavirus. 2020:109."}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u2013271.", "ArticleIdList": ["PMC7054408", "32020029"]}, {"Citation": "C. Liu, Q. Zhou, Y. Li, L. V Garner, S.P. Watkins, L.J. Carter, J. Smoot, A.C. Gregg, A.D. Daniels, S. Jervey, Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases, (2020).", "ArticleIdList": ["32226821"]}, {"Citation": "Naidoo D., Maharaj V., Crouch N.R., Ngwane A. New labdane-type diterpenoids from Leonotis leonurus support circumscription of Lamiaceae sl. Biochem. Syst. Ecol. 2011;3:216\u2013219."}, {"Citation": "Prabhu K.S., Lobo R., Shirwaikar A.A., Shirwaikar A. Ocimum gratissimum: a review of its chemical, pharmacological and ethnomedicinal properties. Open Complement. Med. J. 2009:1.", "ArticleIdList": ["19126292"]}, {"Citation": "de Melo N.I., de Carvalho C.E., Fracarolli L., Cunha W.R., Veneziani R.C., Martins C.H., Crotti A.E. Antimicrobial activity of the essential oil of Tetradenia riparia (Hochst.) Codd. (Lamiaceae) against cariogenic bacteria. Braz. J. Microbiol. 2015;46:519\u2013525.", "ArticleIdList": ["PMC4507545", "26273268"]}, {"Citation": "Garaniya N., Bapodra A. Ethno botanical and phytopharmacological potential of Abrus precatorius L.: a review. Asian Pac. J. Trop. Biomed. 2014;4:S27\u2013S34.", "ArticleIdList": ["PMC4025349", "25183095"]}, {"Citation": "Du Toit A., Van der Kooy F. Artemisia afra, a controversial herbal remedy or a treasure trove of new drugs? J. Ethnopharmacol. 2019;244", "ArticleIdList": ["31376515"]}, {"Citation": "Adj\u00e9 F.A., Koffi E.N., Kon\u00e9 K.Y., Meudec E., Adima A.A., Lozano P.R., Lozano Y.F., Gaydou E.M. Polyphenol characterization in red beverages of Carapa procera (DC) leaf extracts. Beverages. 2019;5:68."}, {"Citation": "Mangoale R.M., Afolayan A.J. Effects of rhizome length and planting depth on the emergence and growth of Alepidea amatymbica Eckl. & Zeyh. Plants. 2020;9:732.", "ArticleIdList": ["PMC7356850", "32532006"]}, {"Citation": "Paper D.H., Karall E., Kremser M., Krenn L. Comparison of the antiinflammatory effects of Drosera rotundifolia and Drosera madagascariensis in the HET-CAM assay. Phyther. Res. An Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2005;19:323\u2013326.", "ArticleIdList": ["16041727"]}, {"Citation": "Yin W., Mao C., Luan X., Shen D.-D., Shen Q., Su H., Wang X., Zhou F., Zhao W., Gao M. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020;368(80):1499\u20131504.", "ArticleIdList": ["PMC7199908", "32358203"]}, {"Citation": "Yang Z., Lasker K., Schneidman-Duhovny D., Webb B., Huang C.C., Pettersen E.F., Goddard T.D., Meng E.C., Sali A., Ferrin T.E., Chimera UCSF. MODELLER, and IMP: an integrated modeling system. J. Struct. Biol. 2012;179:269\u2013278.", "ArticleIdList": ["PMC3410985", "21963794"]}, {"Citation": "Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Guo X. Syst. Comp. Two Anim. Transm. Hum. Coronaviruses SARS-CoV-2 SARS-CoV. Viruses. 2020;12:244. n.d.", "ArticleIdList": ["PMC7077191", "32098422"]}, {"Citation": "Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 2012;4:1\u201317.", "ArticleIdList": ["PMC3542060", "22889332"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Kehinde I., Ramharack P., Nlooto M., Gordon M. The pharmacokinetic properties of HIV-1 protease inhibitors: a computational perspective on herbal phytochemicals. Heliyon. 2019;5:e02565.", "ArticleIdList": ["PMC6838811", "31720444"]}, {"Citation": "Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., Klein M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79:926\u2013935."}, {"Citation": "Basconi J.E., Shirts M.R. Effects of temperature control algorithms on transport properties and kinetics in molecular dynamics simulations. J. Chem. Theory Comput. 2013;9:2887\u20132899.", "ArticleIdList": ["26583973"]}, {"Citation": "Ryckaert J.-P., Ciccotti G., Berendsen H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977;23:327\u2013341."}, {"Citation": "Izaguirre J.A., Catarello D.P., Wozniak J.M., Skeel R.D. Langevin stabilization of molecular dynamics. J. Chem. Phys. 2001;114:2090\u20132098."}, {"Citation": "Seifert E. OriginPro 9.1: scientific data analysis and graphing software-software review. J. Chem. Inf. Model. 2014;54:1552.", "ArticleIdList": ["24702057"]}, {"Citation": "Ylilauri M., Pentik\u00e4inen O.T. MMGBSA as a tool to understand the binding affinities of filamin\u2013peptide interactions. J. Chem. Inf. Model. 2013;53:2626\u20132633.", "ArticleIdList": ["23988151"]}, {"Citation": "Zumla A., Chan J.F.W., Azhar E.I., Hui D.S.C., Yuen K.-Y. Coronaviruses- drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016;15:327\u2013347.", "ArticleIdList": ["PMC7097181", "26868298"]}, {"Citation": "Alexpandi R., De Mesquita J.F., Pandian S.K., Ravi A.V. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and Spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis. Front. Microbiol. 2020;11:1796.", "ArticleIdList": ["PMC7390959", "32793181"]}, {"Citation": "Islam R., Parves M.R., Paul A.S., Uddin N., Rahman M.S., Al Mamun A., Hossain M.N., Ali M.A., Halim M.A. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J. Biomol. Struct. Dyn. 2021;39:3213\u20133224.", "ArticleIdList": ["PMC7232885", "32340562"]}, {"Citation": "Obakachi V.A., Kushwaha N.D., Kushwaha B., Mahlalela M.C., Shinde S.R., Kehinde I., Karpoormath R. Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells. J. Mol. Struct. 2021;1241", "ArticleIdList": ["PMC8118388", "34007088"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C. Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "John S.E.S., Tomar S., Stauffer S.R., Mesecar A.D. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4\u2014The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS) Bioorg. Med. Chem. 2015;23:6036\u20136048.", "ArticleIdList": ["PMC5433438", "26190463"]}, {"Citation": "Jamiu A.T., Pohl C.H., Bello S., Adedoja T., Sabiu S. A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets. All Life. 2021;14:1100\u20131128. doi: 10.1080/26895293.2021.2013327.", "ArticleIdList": ["10.1080/26895293.2021.2013327"]}, {"Citation": "Bordogna A., Pandini A., Bonati L. Predicting the accuracy of protein\u2013ligand docking on homology models. J. Comput. Chem. 2011;32:81\u201398.", "ArticleIdList": ["PMC3057020", "20607693"]}, {"Citation": "Hosseini M., Chen W., Xiao D., Wang C. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs, Precis. Clin. Med. 2021;4:1\u201316.", "ArticleIdList": ["PMC7928605", "33842834"]}, {"Citation": "Sindhu T., Srinivasan P. Exploring the binding properties of agonists interacting with human TGR5 using structural modeling, molecular docking and dynamics simulations. RSC Adv. 2015;5:14202\u201314213."}, {"Citation": "Aribisala J.O, Nkosi S., Idowu K., Nurain I.O, Makolomakwa G.M., Shode F.O., Sabiu S. Astaxanthin-mediated bacterial lethality: Evidence from oxidative stress contribution and molecular dynamics simulation. Oxid. Med. Cell. Longev. 2021:24. doi: 10.1155/2021/7159652. Article ID 7159652pages.", "ArticleIdList": ["10.1155/2021/7159652", "PMC8677388", "34925700"]}, {"Citation": "Uhomoibhi J.O, Shode F.O, Idowu K.A, Sabiu S. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2. J. Mol. Graphics Modell. 2022;114 doi: 10.1016/j.jmgm.2022.108185.", "ArticleIdList": ["10.1016/j.jmgm.2022.108185", "PMC9002601", "35430474"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "4"}, {"Year": "2022", "Month": "4", "Day": "13"}, {"Year": "2022", "Month": "7", "Day": "10"}, {"Year": "2022", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "7", "Day": "20", "Hour": "4", "Minute": "11"}, {"Year": "2022", "Month": "7", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35856008", "PMC9279166", "10.1016/j.sciaf.2022.e01279", "S2468-2276(22)00186-7"]}}], "PubmedBookArticle": []}